Shearman & Sterling Advises Quest Diagnostics Incorporated on $500 Million Senior Notes Offering
Shearman & Sterling represented Quest Diagnostics Incorporated in a shelf takedown of $500 million aggregate principal amount of its 3.450% senior notes due 2026. Goldman, Sachs & Co., Mizuho Securities USA Inc. and Wells Fargo Securities, LLC acted as joint book-running managers for the offering.
Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.
The following Shearman & Sterling attorneys advised Quest Diagnostics Incorporated in this transaction: of counsel Robert C. Treuhold (New York-Capital Markets); partner Stephen Giove (New York-Capital Markets); and associates Minsoo Kwon (New York-Capital Markets) and Daniel Yao (New York-Corporate). Other key members of the team included partner Douglas R. McFadyen (New York-Tax) and associate Adam Sternberg (New York-Tax).